The Management of Recurrent Urinary Tract Infection: Non-Antibiotic Bundle Treatment.

Bundle Cranberry D-mannose Lifestyle Phytotherapy Probiotics

Journal

Probiotics and antimicrobial proteins
ISSN: 1867-1314
Titre abrégé: Probiotics Antimicrob Proteins
Pays: United States
ID NLM: 101484100

Informations de publication

Date de publication:
16 Aug 2023
Historique:
accepted: 11 08 2023
medline: 16 8 2023
pubmed: 16 8 2023
entrez: 16 8 2023
Statut: aheadofprint

Résumé

Recurrent urinary tract infections (rUTIs) are a common condition with high morbidity and negatively impact the quality of life. They account for approximately 25% of all antibiotic prescriptions and are a public health concern in an era of increasing multidrug-resistant organisms (MDROs). Several non-antibiotic treatment strategies have been tried to curb antimicrobial use, and many are effective to some degree, but no experience testing multimodal interventions. We created a "care bundle" consisting of behavioral interventions, vaginal and oral probiotics, D-mannose, and cranberry to be followed for six months. We enrolled women with rUTIs over three years. Changes in urinary tract infections, antibiotic use, chronic symptoms, and quality of life were compared in the six months before and after participation in the study. Forty-seven women were enrolled in the study, six of whom were excluded from the final analysis. We observed a 76% reduction in urinary tract infections (p < 0.001) and a reduction in total antibiotic exposure of more than 90% (p < 0.001); all chronic symptoms showed a trend toward reduction. Adherence to the bundle was high (87.2%). Overall, 80.5% of women experienced an improvement in their quality of life. In our experience, a bundle protocol is effective in reducing recurrences and antimicrobial use in a cohort of women with rUTIs and results in a subjective improvement in chronic symptoms and quality of life. Further research with larger sample size is needed to confirm these findings.

Identifiants

pubmed: 37584833
doi: 10.1007/s12602-023-10141-y
pii: 10.1007/s12602-023-10141-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Foxman B (2014) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 28(1):1–13
doi: 10.1016/j.idc.2013.09.003 pubmed: 24484571
Beerepoot M, Geerlings S (2016) Non-antibiotic prophylaxis for urinary tract infections. Pathogens 5(2):36
doi: 10.3390/pathogens5020036 pubmed: 27092529 pmcid: 4931387
Hu S, Hao Y, Zhang X et al (2023) Lacticaseibacillus casei LH23 suppressed HPV gene expression and inhibited cervical cancer cells. Probiotics Antimicrob Prot 15:443–450
doi: 10.1007/s12602-021-09848-7
Alonzo Martínez MC, Cazorla E, Cánovas E, Martínez-Blanch JF et al (2021) Study of the vaginal microbiota in healthy women of reproductive age. Microorganisms 9(5):1069
doi: 10.3390/microorganisms9051069 pubmed: 34063526 pmcid: 8156707
Ravel J, Gajer P, Abdo Z, Schneider GM et al (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 108:4680–4687
doi: 10.1073/pnas.1002611107 pubmed: 20534435
Miko E, Barakonyi A (2023) The role of hydrogen-peroxide (H
doi: 10.3390/antiox12051055 pubmed: 37237921 pmcid: 10215881
Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J, Fihn SD (2004) Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med 164(9):989–993
doi: 10.1001/archinte.164.9.989 pubmed: 15136308
Beetz R (2003) Mild dehydration: a risk factor of urinary tract infection? Eur J Clin Nutr 57:S52
doi: 10.1038/sj.ejcn.1601902 pubmed: 14681714
Hooton TM, Vecchio M, Iroz A et al (2018) Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections: a randomized clinical trial. JAMA Intern Med 178:1509–1515
doi: 10.1001/jamainternmed.2018.4204 pubmed: 30285042 pmcid: 6584323
Hooton TM (2001) Recurrent urinary tract infection in women. Int J Antimicrob Agents 17(4):259–268
doi: 10.1016/S0924-8579(00)00350-2 pubmed: 11295405
Kranjčec B, Papeš D, Altarac S (2014) D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 32(1):79–84
doi: 10.1007/s00345-013-1091-6 pubmed: 23633128
Valentine-King MA, Trautner BW, Zoorob RJ, Germanos G, Hansen M, Salemi JL et al (2022) Analysis of recurrent urinary tract infection management in women seen in outpatient settings reveals opportunities for antibiotic stewardship interventions. Antimicrob Steward Health Epidemiol 2(1):e8
doi: 10.1017/ash.2021.224
Di Vico T, Morganti R, Cai T, Naber KG, Wagenlehner et al (2020) Acute cystitis symptom score (ACSS): clinical validation of the Italian version. Antibiotics (Basel) 9(3):104
De Rosa R, Grosso S, Lorenzi G, Bruschetta G, Camporese A (2018) Evaluation of the new Sysmex UF-5000 fluorescence flow cytometry analyser for ruling out bacterial urinary tract infection and for prediction of Gram-negative bacteria in urine cultures. Clin Chim Acta 484:171–178
doi: 10.1016/j.cca.2018.05.047 pubmed: 29803898
McGroarty JA, Tomeczek L, Pond DG, Reid G, Bruce AW (1992) Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9. J Infect Dis 165(6):1142–1144
doi: 10.1093/infdis/165.6.1142 pubmed: 1316413
Gupta G (2005) Microbicidal spermicide or spermicidal microbicide? Eur J Contracept Reprod Health Care 10(4):212–218
doi: 10.1080/13625180500280753 pubmed: 16448947
Jagtap S, Harikumar S, Vinayagamoorthy V, Mukhopadhyay S, Dongre A (2022) Comprehensive assessment of holding urine as a behavioral risk factor for UTI in women and reasons for delayed voiding. BMC Infect Dis 22(1):521
doi: 10.1186/s12879-022-07501-4 pubmed: 35668379 pmcid: 9172065
Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 14(1):11–6
Howell A, Souza D, Roller M, Fromentin E (2015) Comparison of the anti-adhesion activity of three different cranberry extracts on uropathogenic P-fimbriated Escherichia coli: a randomized, double-blind, placebo-controlled, ex vivo, acute study. Nat Prod Commun 10(7):1215–1218
pubmed: 26411014
Akil I, Yilmaz O, Kurutepe S, Degerli K, Kavukcu S (2006) Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora. Pediatr Nephrol 21(6):807–810
doi: 10.1007/s00467-006-0088-4 pubmed: 16703374
Kailasapathy K, Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78(1):80–88
doi: 10.1046/j.1440-1711.2000.00886.x pubmed: 10651933
Ching CB (2022) Non-antibiotic approaches to preventing pediatric UTIs: a role for D-mannose, cranberry, and probiotics? Curr Urol Rep 23(6):113–127
doi: 10.1007/s11934-022-01094-w pubmed: 35441976
Schwenger EM, Tejani AM, Loewen PS (2015) Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev 2015(12):CD008772
Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E et al (2018) The urinary tract microbiome in health and disease. Eur Urol Focus 4:128–138
doi: 10.1016/j.euf.2016.11.001 pubmed: 28753805
Jones-Freeman B, Chonwerawong M, Marcelino VR, Deshpande AV, Forster SC, Starkey MR (2021) The microbiome and host mucosal interactions in urinary tract diseases. Mucosal Immunol 14(4):779–792
doi: 10.1038/s41385-020-00372-5 pubmed: 33542492
Sihra N, Goodman A, Zakri R, Sahai A, Malde S (2018) Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol 15(12):750–776
doi: 10.1038/s41585-018-0106-x pubmed: 30361493
De Llano DG, Arroyo A, Cárdenas N, Rodríguez JM, Moreno-Arribas MV, Bartolomé B (2017) Strain-specific inhibition of the adherence of uropathogenic bacteria to bladder cells by probiotic Lactobacillus spp. Pathog Dis 75(4)
Siempos II, Ntaidou TK, Falagas ME (2010) Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 38(3):954–962
doi: 10.1097/CCM.0b013e3181c8fe4b pubmed: 20016381
Dimidi E, Christodoulides S, Scott SM, Whelan K (2017) Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr 8(3):484–494
doi: 10.3945/an.116.014407 pubmed: 28507013 pmcid: 5421123
Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE (2017) Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care. 2016 Aug 19; 19:262. Erratum in: Crit Care 21(1):42
Chen CC, Lai CC, Huang HL, Huang WY, Toh HS, Weng TC, Chuang YC, Lu YC, Tang HJ (2019) Antimicrobial activity of Lactobacillus species against carbapenem-resistant Enterobacteriaceae. Front Microbiol 18(10):789
doi: 10.3389/fmicb.2019.00789
El-Mokhtar MA, Hassanein KM, Ahmed AS, Gad GF, Amin MM, Hassanein OF (2020) Antagonistic activities of cell-free supernatants of lactobacilli against extended-spectrum β-lactamase producing Klebsiella pneumoniae and Pseudomonas aeruginosa. Infect Drug Resist 17(13):543–552
doi: 10.2147/IDR.S235603
Leventogiannis K, Gkolfakis P, Spithakis G, Tsatali A, Pistiki A, Sioulas A, Giamarellos-Bourboulis EJ, Triantafyllou K (2019) Effect of a Preparation of four probiotics on symptoms of patients with irritable bowel syndrome: association with intestinal bacterial overgrowth. Probiotics Antimicrob Proteins 11(2):627–634. Erratum in: Probiotics Antimicrob Proteins. 2018 Mar 28; PMID: 29508268; PMCID: PMC6541575
Chen TC, Tsai JP, Huang HJ, Teng CC, Chien SJ, Kuo HC, Huang WS, Chen CN (2011) Regulation of cyclooxygenase-2 expression in human bladder epithelial cells infected with type I fimbriated uropathogenic E. coli. Cell Microbiol 13(11):1703–13
Cooper TE, Teng C, Howell M, Teixeira-Pinto A, Jaure A, Wong G (2022) D-mannose for preventing and treating urinary tract infections. Cochrane Database Syst Rev 8(8):CD013608
Koradia P, Kapadia S, Trivedi Y, Chanchu G, Harper A (2018) Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women: a controlled pilot study. Expert Rev Anti Infect Ther 17(9):733–740. Erratum in: Expert Rev Anti Infect Ther. 2019; Sep 27:1
Pugliese D, Acampora A, Porreca A, Schips L, Cindolo L (2020) Effectiveness of a novel oral combination of D-Mannose, pomegranate extract, prebiotics and probiotics in the treatment of acute cystitis in women. Arch Ital Urol Androl 92(1):34–38
doi: 10.4081/aiua.2020.1.34 pubmed: 32255320

Auteurs

Sergio Venturini (S)

Department of Infectious Diseases, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Ingrid Reffo (I)

Department of Anaesthesia and Intensive Care, ASFO Santa Maria dei Battuti Hospital of San Vito al Tagliamento (Pordenone), Pordenone, Italy. ingrid.reffo@asfo.sanita.fvg.it.

Manuela Avolio (M)

Department of Microbiology, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Giancarlo Basaglia (G)

Department of Microbiology, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Giovanni Del Fabro (G)

Department of Infectious Diseases, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Astrid Callegari (A)

Department of Infectious Diseases, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Maurizio Tonizzo (M)

Department of Internal Medicine, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Anna Sabena (A)

Department of Internal Medicine, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Stefania Rondinella (S)

Department of Internal Medicine, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Walter Mancini (W)

Department of Nephrology, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Carmina Conte (C)

Department of Nephrology, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Massimo Crapis (M)

Department of Infectious Diseases, ASFO Santa Maria degli Angeli Hospital of Pordenone, Pordenone, Italy.

Classifications MeSH